Navigation Links
Biomarkers Market: Epigenetic & MicroRNA Biomarkers Report

DALLAS, Aug. 16, 2013 /PRNewswire-iReach/ -- The epigenetic and microRNA biomarkers fields are co-evolving and have reached a critical point wherein enough signatures have been identified across various different disease classes, most notably in cancer, that some of these signatures/expression patterns can be validated and deployed for use in the clinic.  However, these biomarker fields are evolving in parallel with the research marketplace, and this market report characterizes the research markets for both these fields so as to present a comprehensive analysis that en bloc provides a complete picture of this expanding marketplace.


The Epigenetic and MicroRNA Biomarkers 2013 Market Report

( ) is written in PowerPoint and is delivered to customers in this format enabling convenient drag-and-drop into R&D Presentations, Business Plans, Investor Presentations.  Associated files that constitute the complete report package are in Excel and PDF formats.

Specific Topics Addressed in this Market Report:

  • Epigenetics Research Market Analysis
    • Primary Market Survey to Characterize Research Market Trends based on Data Collected from Researchers
    • Breakout of Epigenetics Research Activity based on Epigenetic Modifications Studied
    • Segmentation of Epigenetics Research Activity based on Disease Classes Studied
    • Epigenetics Research Activity in Cancer--Quantitative Segmentation
    • Reagent Kits and Products in the Epigenetics Research Field [Details of Products from the Vendors in this Space are Presented and Analyzed]
  • Epigenetics Biomarkers
  • En masse Analysis of All Epigenetics-focused Publications and Trends from these Data with respect to Potential Epigenetics Biomarkers
  • Description of Epigenetic Biomarkers Identified to Date in Various Cancer Classes [Nature of Epigenetic Signature, Potential Role in Prognostics and Diagnostics]
  • Primary Market Survey Data Presents a Complete Picture of the microRNA Research Field based on End-User/Researcher Practices
  • Methodologies and Market Breakout for Expression Profiling
  • Quantitative Breakout of the microRNA Research Market Across the Research Workflow
  • Product Vendors and their Quantitative Penetrance in the microRNA Research Markets
  • Expression Patterns/Signatures of microRNAs in Different Disease States
  • Prognostic/Diagnostic Potential of microRNA Expression Patterns
  • microRNAs in Biological Fluids as Circulating Biomarkers: List and Significance
  • Traditional Cancer Biomarkers
  • Oncogenes
  • Tumor-Suppressor Genes
  • Up-to-date List of CDx on the Marketplace
  • Partnerships in the CDx Space
  • MicroRNA Research Market Analysis
  • MicroRNA Biomarkers Analysis
  • Cancer Biomarker Classes
  • Companion Diagnostics (CDx)

Buy a copy of this report at .

Table of Contents for the Epigenetic and MicroRNA Biomarkers 2013 Market Report:

Chapter I. Epigenetics Research Market Analysis
Primary market survey to Characterize Marketplace from the
Bottom-up: Qualitative and Qualitative Market Data
Current Research Paradigms
Quantitative Segmentation of Epigenetics Research
Epigenetics research in Cancer: Quantitative Segmentation
Commercial kit and Reagent offering in the Epigenetics Research Marketplace

Chapter II. Epigenetic Signature as Potential Biomarkers
Big Data Analysis of Epigenetics Publication Landscapes
Hotspot Analysis of Publications Describes Segments of Opportunity vis-a-vis Research Product Development as well Potential Assay Development for Disease Associations, Harvesting of Prognostic as well as Diagnostic Biomarkers
Epigenetic Signatures Described in Various Disease Classes
DNA Methylation as Disease Biomarkers
Histone Modification as Disease Biomarkers
Potential Epigenetic Biomarkers in Various Cancer Classes
Gastric Cancer
Pancreatic Cancer
Prostate Cancer

Chapter III. micrRNA Research Market Analysis microRNA Signatures as Potential Biomarkers
Primary Market Survey to Characterize Marketplace from the Bottom-Up: Quantitative and Quantitative Market Data
microRNA Research vis-à-vis Content Classes
microRNA Research in Cancer
microRNA Research Workflow: Quantitative Breakout
microRNA Expression Profiling Quantitative market breakout
microRNA Vendor Market Penetration Space Map
NGS to study micrRNAs-Market Breakout by Platform
Unmet Needs in the microRNA Research Space
microRNA Signatures Describes in Various Disease Classes: Potential for Biomarkers Development
Tumor Suppressor microRNA Methylatoin
microRNA in Biofluids
Circulating microRNAs as Potential Tumor Markers

Chapter IV. Characterization of Molecular Biomarker Classes
Traditional Cancer Biomarkers
Tumor Suppressor Genes

Appendix I. Epigenetics and MicroRNA Biomarkers Summary

Appendix II. List of Companion Diagnostics (Cdx) on the Market, In Progress Cdx in Development/Partnership, Potential Market Size for Epigenetics and microRNA-based CDx

Appendix III. Research Methodology

Complete report available at .

You may also be interested in other reports we have biomarkers:

PharmaFocus: Biomarkers in Alzheimer's Disease at .

Biomarker Partnering Terms and Agreements at .

Metabolomics (Biomarker Discovery/Metabolite Detection/Metabolite Profiling) Market By Applications (Drug Discovery/Toxicology Assessment/ Diagnosis) and Indications (Oncology/Cardiology/Neurology) – Forecasts from 2012 to 2017 at .

Explore all reports on biomarkers market at .

About Us: is an online market research reports library of 350,000+ in-depth studies of over 5000 micro markets. Our database includes reports by leading publishers from across the globe. Call +1 888 391 5441 with your research requirements.

Media Contact: Priyank Tiwari,, +1 888 391 5441,

News distributed by PR Newswire iReach:

Copyright©2012 PR Newswire.
All rights reserved

Related biology news :

1. HUNT Biosciences and SomaLogic collaborate to validate protein biomarkers of cardiovascular risk
2. Trial seeks improved lung-cancer screening by combining imaging and biomarkers
3. Air pollution level changes in Beijing linked with biomarkers of cardiovascular disease
4. VTT and GE Healthcare developing novel biomarkers to predict Alzheimers disease
5. VEGF Inhibition: Therapy-Indicating and Prognostic Biomarkers, 2013
6. Spanish researchers design biomarkers for the detection of dengue and West Nile virus
7. NIH funds research to identify Parkinsons biomarkers
8. New AAN/ALS Association Clinical Fellow Will Pursue Immune Biomarkers
9. Epigenetic biomarkers may predict if a specific diet and exercise regimen will work
10. Novel biomarkers improve diagnosis in rheumatoid arthritis
11. hESC Products Market: Human Embryonic Stem Cell Patent IP Landscape Opportunity Analysis in New Research Report
Post Your Comments:
(Date:10/8/2015)... , Oct. 8, 2015 Synaptics ... human interface solutions, announced today that it will ... fiscal 2016 on Thursday, October 22, 2015, after ... a corresponding conference call for analysts and investors ... which management may discuss forward-looking information.    ...
(Date:10/6/2015)... LAKE CITY , Oct. 6, 2015 ... company, announced today that it has signed a contract ... monitoring services across the full range of sentences under ... Group,s President of the Americas. "This contract with the ... region of the US and advances our position as ...
(Date:9/30/2015)...  With nearly 300,000 Americans living with spinal cord ... to reach 12,500 annually, the role of Independent Living ... Independent Living (SCRS-IL) is increasingly important. SCRS-IL is ... opening doors to independence for individuals with SCIs ... assistive technology services and education. "In serving ...
Breaking Biology News(10 mins):
(Date:10/12/2015)... , Oct. 12, 2015 This report ... which include cell type, products, applications, end-user markets and ... REPORT HIGHLIGHTS The global cell expansion market generated ... expected to reach revenues of $9.7 billion in 2015 ... growth rate (CAGR) of 17.8% from 2015 to 2020. ...
(Date:10/12/2015)... -- cell surface marker detection market is ... a new report by Grand View Research, Inc. This growth ... oncology diseases and other cell-associated disorders. --> cell ... 6.49 billion by 2022, according to a new report by ... attributed to rise in incidence of oncology diseases and other ...
(Date:10/12/2015)... , Oct. 12, 2015 /PRNewswire/ - Aeterna Zentaris ... biopharmaceutical company engaged in developing and commercializing novel treatments ... departure of Dennis Turpin , the Company,s former ... to close its Quebec City ... President and Chief Executive Officer of the Company commented, ...
(Date:10/12/2015)... 12, 2015 LabStyle Innovations Corp. ... Solution, today announced its Medical Director, Dr. Moshe ... MobiHealth,s 5th EAI International Conference on Wireless Mobile ... innovations in mobile and wireless technologies," the conference will ... from October 14 - 16, 2015. The conference is ...
Breaking Biology Technology: